Regulations.gov document
Drugs For Human Use; Drug Efficacy Study Implementation; Revocation Of Exemption For…
Notice · FDA-1982-N-0225 · posted Mar 18, 2011
Key facts
| Document ID | FDA-1982-N-0225-0005 |
|---|---|
| Title | Drugs For Human Use; Drug Efficacy Study Implementation; Revocation Of Exemption For Certain Effective Oral Prescription Drugs Offered For Relief Of Symptoms Of Cough, Cold, Or Allergy ("Paragraph XIV/ Category 15); Followup Notice And Opportunity For Hearing |
| Document type | Notice |
| Subtype | Notice of Opportunity of Hearing |
| Agency | FDA |
| Docket | FDA-1982-N-0225 |
| Posted | Mar 18, 2011 |
| Federal Register citation | 47 FR 23809 |
| FR document number | 82-14713 |
| Comment period opens | Mar 18, 2011 |
| Comments due | Jul 2, 1982 |
| Effective date | Apr 23, 1982 |
At a glance
- 10–99 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: